314 related articles for article (PubMed ID: 10796795)
21. Corticosteroid therapy for nephrotic syndrome in children.
Hodson EM; Knight JF; Willis NS; Craig JC
Cochrane Database Syst Rev; 2001; (2):CD001533. PubMed ID: 11405997
[TBL] [Abstract][Full Text] [Related]
22. Corticosteroid therapy for nephrotic syndrome in children.
Hodson EM; Knight JF; Willis NS; Craig JC
Cochrane Database Syst Rev; 2000; (4):CD001533. PubMed ID: 11034723
[TBL] [Abstract][Full Text] [Related]
23. Immunotherapy for Guillain-Barré syndrome: a systematic review.
Hughes RA; Swan AV; Raphaël JC; Annane D; van Koningsveld R; van Doorn PA
Brain; 2007 Sep; 130(Pt 9):2245-57. PubMed ID: 17337484
[TBL] [Abstract][Full Text] [Related]
24. Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial.
Walgaard C; Jacobs BC; Lingsma HF; Steyerberg EW; van den Berg B; Doets AY; Leonhard SE; Verboon C; Huizinga R; Drenthen J; Arends S; Budde IK; Kleyweg RP; Kuitwaard K; van der Meulen MFG; Samijn JPA; Vermeij FH; Kuks JBM; van Dijk GW; Wirtz PW; Eftimov F; van der Kooi AJ; Garssen MPJ; Gijsbers CJ; de Rijk MC; Visser LH; Blom RJ; Linssen WHJP; van der Kooi EL; Verschuuren JJGM; van Koningsveld R; Dieks RJG; Gilhuis HJ; Jellema K; van der Ree TC; Bienfait HME; Faber CG; Lovenich H; van Engelen BGM; Groen RJ; Merkies ISJ; van Oosten BW; van der Pol WL; van der Meulen WDM; Badrising UA; Stevens M; Breukelman AJ; Zwetsloot CP; van der Graaff MM; Wohlgemuth M; Hughes RAC; Cornblath DR; van Doorn PA;
Lancet Neurol; 2021 Apr; 20(4):275-283. PubMed ID: 33743237
[TBL] [Abstract][Full Text] [Related]
25. Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barré syndrome: randomised trial.
van Koningsveld R; Schmitz PI; Meché FG; Visser LH; Meulstee J; van Doorn PA;
Lancet; 2004 Jan; 363(9404):192-6. PubMed ID: 14738791
[TBL] [Abstract][Full Text] [Related]
26. Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy.
Hughes RA; Mehndiratta MM
Cochrane Database Syst Rev; 2012 Aug; (8):CD002062. PubMed ID: 22895925
[TBL] [Abstract][Full Text] [Related]
27. Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy.
Mehndiratta MM; Hughes RA
Cochrane Database Syst Rev; 2001; (3):CD002062. PubMed ID: 11687011
[TBL] [Abstract][Full Text] [Related]
28. Double-blind trial of intravenous methylprednisolone in Guillain-Barré syndrome. Guillain-Barré Syndrome Steroid Trial Group.
Lancet; 1993 Mar; 341(8845):586-90. PubMed ID: 8094828
[TBL] [Abstract][Full Text] [Related]
29. Corticosteroids or ACTH for acute exacerbations in multiple sclerosis.
Filippini G; Brusaferri F; Sibley WA; Citterio A; Ciucci G; Midgard R; Candelise L
Cochrane Database Syst Rev; 2000; (4):CD001331. PubMed ID: 11034713
[TBL] [Abstract][Full Text] [Related]
30. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group.
Lancet; 1997 Jan; 349(9047):225-30. PubMed ID: 9014908
[TBL] [Abstract][Full Text] [Related]
31. Corticosteroids for Bell's palsy (idiopathic facial paralysis).
Salinas RA; Alvarez G; Alvarez MI; Ferreira J
Cochrane Database Syst Rev; 2002; (1):CD001942. PubMed ID: 11869613
[TBL] [Abstract][Full Text] [Related]
32. Corticosteroids for myasthenia gravis.
Schneider-Gold C; Gajdos P; Toyka KV; Hohlfeld RR
Cochrane Database Syst Rev; 2005 Apr; 2005(2):CD002828. PubMed ID: 15846640
[TBL] [Abstract][Full Text] [Related]
33. WITHDRAWN: Corticosteroids for Bell's palsy (idiopathic facial paralysis).
Salinas RA; Alvarez G; Ferreira J
Cochrane Database Syst Rev; 2009 Apr; (2):CD001942. PubMed ID: 19370572
[TBL] [Abstract][Full Text] [Related]
34. Safety and efficacy of eculizumab in Guillain-Barré syndrome: a multicentre, double-blind, randomised phase 2 trial.
Misawa S; Kuwabara S; Sato Y; Yamaguchi N; Nagashima K; Katayama K; Sekiguchi Y; Iwai Y; Amino H; Suichi T; Yokota T; Nishida Y; Kanouchi T; Kohara N; Kawamoto M; Ishii J; Kuwahara M; Suzuki H; Hirata K; Kokubun N; Masuda R; Kaneko J; Yabe I; Sasaki H; Kaida KI; Takazaki H; Suzuki N; Suzuki S; Nodera H; Matsui N; Tsuji S; Koike H; Yamasaki R; Kusunoki S;
Lancet Neurol; 2018 Jun; 17(6):519-529. PubMed ID: 29685815
[TBL] [Abstract][Full Text] [Related]
35. Glucocorticoid corticosteroids for Duchenne muscular dystrophy.
Manzur AY; Kuntzer T; Pike M; Swan A
Cochrane Database Syst Rev; 2008 Jan; (1):CD003725. PubMed ID: 18254031
[TBL] [Abstract][Full Text] [Related]
36. Immunotherapy for IgM anti-Myelin-Associated Glycoprotein paraprotein-associated peripheral neuropathies.
Lunn MP; Nobile-Orazio E
Cochrane Database Syst Rev; 2003; (1):CD002827. PubMed ID: 12535440
[TBL] [Abstract][Full Text] [Related]
37. Corticosteroids for Bell's palsy (idiopathic facial paralysis).
Salinas RA; Alvarez G; Ferreira J
Cochrane Database Syst Rev; 2004 Oct; (4):CD001942. PubMed ID: 15495021
[TBL] [Abstract][Full Text] [Related]
38. Treatment for Lambert-Eaton myasthenic syndrome.
Maddison P; Newsom-Davis J
Cochrane Database Syst Rev; 2003; (2):CD003279. PubMed ID: 12804456
[TBL] [Abstract][Full Text] [Related]
39. Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy.
Mehndiratta MM; Hughes RA
Cochrane Database Syst Rev; 2002; (1):CD002062. PubMed ID: 11869620
[TBL] [Abstract][Full Text] [Related]
40. Corticosteroids for preventing postherpetic neuralgia.
He L; Zhang D; Zhou M; Zhu C
Cochrane Database Syst Rev; 2008 Jan; (1):CD005582. PubMed ID: 18254083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
